What's breaking now, across thousands of outlets.
When Exelixis CEO Michael Morrissey rolled out the biotech's final numbers for 2025 earlier in the year, there was no mistaking the outsized role that cabozantinib played in funding the company and keeping its stock ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
The pharma industry is bringing its 340B fight to Illinois. AbbVie, Novartis and Bristol Myers Squibb each filed separate lawsuits over the last week against an Illinois state law that seeks to…
What if certain signs of the disease were to manifest subtly during sleep, long before the first memory problems appear? This is the line of inquiry being explored by a team of researchers at ULiège.
An innovative youth mental health service model can improve care and ease pressure on Canada's health care system, a new study led by researchers at McGill University demonstrates.
Hospitals and allied health providers are concerned that insurers are asking providers for their patients' full clinical history.
The “compassionate allowances” list speeds consideration for benefits.
The “compassionate allowances” list speeds consideration for benefits.
